Stay updated on GEMINI 1 Tolebrutinib Clinical Trial
Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page
- ChecktodayChange DetectedThe page now displays Revision: v3.3.4 instead of Revision: v3.3.3; this is a metadata update and does not affect study content or functionality.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedLocations section updated with additions and deletions of multiple study sites across the US, Canada, and other countries, altering the geographic footprint of the trial. This may impact where participants can enroll and how the study is accessed.SummaryDifference2%

- Check45 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe Publications section now notes that PubMed publications are automatically filled from PubMed and includes Revision: v3.3.1; the older manual PubMed listing language and Revision: v3.2.0 were removed.SummaryDifference0.0%

- Check59 days agoChange DetectedRemoved the government funding status banner informing users that information may not be up to date due to a lapse in funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedResults for NCT04410978 GEMINI 1 were posted on ClinicalTrials.gov, including the NEJM 2025 publication by Oh et al.; the page now lists updated outcome measures and key study dates.SummaryDifference0.2%

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.